To harness groundbreaking science and cutting-edge vaccine technologies (through partnerships) to develop safe, accessible, and effective vaccines that protect humanity from infectious diseases, pandemics, and bioterrorism threats.
At Malaika Vx, we strive for the highest standards in research, innovation, and evidence-based solutions.
At Malaika Vx, we are dedicated to partnering with research institutions and established partners to achieve lasting impact. We believe that the best results come from working together.
At Malaika Vx, we pioneer next-generation vaccine technologies that combine advanced antigen targeting with cutting-edge delivery platforms to achieve transformative, universal solutions for global health challenges, while honouring the achievements of our scientific past.
At Malaika Vx, we are devoted to ensuring vaccines reach the most vulnerable and underserved populations worldwide.
Malaiaka Vx has established the Francis A Plummer Trust, holding founding shares of the Company, to ensure those that have been there since the beginning, namely the Pumwani cohort and Kenyan scientists, are shareholders and beneficiaries of the efforts of the Company to commercialize the technology.
Copyright © 2024 Malaika website - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.